Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Digital HLA allelotyping.

Ozlem Topaloglu1, Curt I Civin, Fred Bunz

  • 1Department of Radiation Oncology and Molecular Radiation Sciences, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Maryland 21231, USA.

Cancer Biology & Therapy
|August 25, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MiR-513a promotes human erythroid differentiation by modulating c-Jun.

FEBS open bio·2026
Same author

Augmenting the Anti-Leukemic Activity of the BCL-2 Inhibitor Venetoclax Through Its Transformation Into Polypharmacologic Dual BCL-2/HDAC1 and Dual BCL-2/HDAC6 Inhibitors.

Drug development research·2025
Same author

Dynamic Modulation of IRE1α-XBP1 Signaling by Adenovirus.

Pathogens (Basel, Switzerland)·2025
Same author

Robust p53 phenotypes and prospective downstream targets in telomerase-immortalized human cells.

Oncotarget·2025
Same author

The polypharmacy combination of the BCL-2 inhibitor venetoclax (VEN) and the FLT3 inhibitor gilteritinib (GIL) is more active in acute myeloid leukemia cells than novel polypharmacologic BCL-2/FLT3 VEN-GIL hybrid single-molecule inhibitors.

European journal of medicinal chemistry·2025
Same author

Dynamic modulation of IRE1α-XBP1 signaling by adenovirus.

bioRxiv : the preprint server for biology·2024
Same journal

Effective treatment of human breast tumors by chimeric CCL2 and CCL8 diphtheria toxin cytotoxic peptides.

Cancer biology & therapy·2026
Same journal

<i>NSUN2</i> mediates <i>SALL2</i> m5C methylation to inhibit ferroptosis and promote breast cancer progression.

Cancer biology & therapy·2026
Same journal

Targeting the PI3K/AKT pathway in prostate cancer: the role of PTEN deficiency and biomarker-guided therapy.

Cancer biology & therapy·2026
Same journal

ABHD17C regulates the efficacy of lenvatinib in suppressing hepatocellular carcinoma.

Cancer biology & therapy·2026
Same journal

Advances in SEC61G research: from ER translocon subunit to emerging pan-cancer oncogenic roles.

Cancer biology & therapy·2026
Same journal

Efficacy and safety profiles of CDK4/6 inhibitor in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (ABC) from the high-altitude <i>versus</i> low-altitude regions: a multi-center retrospective study.

Cancer biology & therapy·2026
See all related articles

Accurate human leukocyte antigen (HLA) matching is crucial for successful stem cell transplants. A new method, Digital HLA Allelotyping (dig-HLA), overcomes challenges in typing heterozygote individuals for improved patient outcomes.

Area of Science:

  • Immunogenetics
  • Transplantation immunology
  • Molecular diagnostics

Background:

  • Stem cell transplantation offers curative potential for neoplastic disorders.
  • Successful engraftment relies on human leukocyte antigen (HLA) allele matching between donor and recipient.
  • HLA incompatibility can lead to graft failure and graft-versus-host disease, impacting patient survival.

Purpose of the Study:

  • To address limitations in current DNA sequence-based HLA typing methods, particularly heterozygosity.
  • To introduce a novel high-resolution HLA analysis technique called Digital HLA Allelotyping (dig-HLA).
  • To improve the accuracy of HLA matching for enhanced stem cell transplantation outcomes.

Main Methods:

  • Development of Digital HLA Allelotyping (dig-HLA) for HLA analysis.

Related Experiment Videos

  • Random sorting and individual identification of expressed HLA alleles.
  • Application of dig-HLA to overcome heterozygosity challenges in HLA typing.

    • Main Results:

    • Demonstration of a novel method for high-resolution HLA analysis.
    • Successful individual identification of expressed HLA alleles.
    • Potential to improve accuracy in HLA matching for clinical transplantation.

    Conclusions:

    • Digital HLA Allelotyping (dig-HLA) offers a promising approach for high-resolution HLA typing.
    • This method effectively addresses challenges posed by heterozygosity in HLA loci.
    • Improved HLA matching through dig-HLA can significantly enhance stem cell transplantation efficacy and patient survival.